2022
DOI: 10.1016/j.molcel.2022.07.011
|View full text |Cite
|
Sign up to set email alerts
|

Mitotic DNA synthesis is caused by transcription-replication conflicts in BRCA2-deficient cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 79 publications
(150 reference statements)
0
16
0
Order By: Relevance
“…It will be important in the future to understand how FANCD2 functionally interacts with SLX4, and with the other members of the FA pathway, to promote SSE-mediated resolution of these structures. Finally, the synthetic proliferation defect and the difference in the impact of SETX depletion in cancerous versus the noncancerous cell lines hint towards therapeutic strategies targeting endogenous RS in tumors, especially in specific genetic backgrounds [71][72][73] or contexts characterized by increased TRCs, such as following oncogene activation, metabolic stress or estrogenstimulated transcription [74][75][76] . For example, even if germline mutations in SETX associated with neurodegenerative disorders do not reportedly increase cancer risk, SETX somatic mutations and CNVs are commonly found in tumors, particularly in gynecological and colon cancers (data from The Cancer Genome Atlas (TGCA) Program) 77 .…”
Section: Discussionmentioning
confidence: 99%
“…It will be important in the future to understand how FANCD2 functionally interacts with SLX4, and with the other members of the FA pathway, to promote SSE-mediated resolution of these structures. Finally, the synthetic proliferation defect and the difference in the impact of SETX depletion in cancerous versus the noncancerous cell lines hint towards therapeutic strategies targeting endogenous RS in tumors, especially in specific genetic backgrounds [71][72][73] or contexts characterized by increased TRCs, such as following oncogene activation, metabolic stress or estrogenstimulated transcription [74][75][76] . For example, even if germline mutations in SETX associated with neurodegenerative disorders do not reportedly increase cancer risk, SETX somatic mutations and CNVs are commonly found in tumors, particularly in gynecological and colon cancers (data from The Cancer Genome Atlas (TGCA) Program) 77 .…”
Section: Discussionmentioning
confidence: 99%
“…During this step, we determine the optimal concentration of CDK1 inhibitor (RO-3306) required to effectively arrest cells released from thymidine block in G2. To do this, we use FACS analyses of DNA content combined with immunofluorescent staining for phosphorylated Histone H3 (Ser10) 1 ( Figure 1 B), which is a marker for cells that entered mitosis. Seed 1.6 × 10 5 H1299 cells per well of a 6-well plate.…”
Section: Before You Beginmentioning
confidence: 99%
“…For complete details on the use and execution of this protocol, please refer to Groelly et al. (2022) 1 and Macheret et al. (2020).…”
mentioning
confidence: 99%
“…Recently, it has been reported that the frequency of MiDAS is elevated in BRCA2 deficient cells [ 157 ]. However, most of the EdU-sequenced regions in BRCA2-deficient mitotic cells did not overlap with APH-induced MiDAS.…”
Section: Mechanisms For Managing Replication Stressmentioning
confidence: 99%
“…These DNA lesions turnout to be the legacy of DNA repair in mitosis. This phenotype was restored upon overexpression of RNase H1 highlighting on the R-loops as a possible inducer of MiDAS [ 157 ].…”
Section: Mechanisms For Managing Replication Stressmentioning
confidence: 99%